Ypsomed Holding AG (0QLQ) Q4 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon. Welcome to Ypsomed full year results presentation for the 2025, 2026 financial year. We're delighted to have you all here with us in Zurich in person and for all of those online. Before we begin, please note this presentation contains forward looking statements that naturally comes with a certainty. Turning to today's agenda, our CEO, Simon Michel, will open with our strategic priorities, go over our business and operations updates. Then followed by CFO, Samuel Kunzli, with a review of the financial results. We will then open the floor to your questions. First, to the people that are joining us here in person and then online. If you'd like to ask a question, please raise your hand, state your name and the company you work for, and then we'll unmute your mic or bring you a mic if you're here in person. Also note, the pre presentation is recorded, and we'll make the recording available after the session online. And without further ado, I will now pass on to Simon, please. Thank you very much. Sam, good afternoon from my side as well and a very warm welcome here in Zurich. We look forward to spending the next hour with you. I would like to start with making three points before I dig into my strategic slides. Number one, we can really say this company has delivered. We have delivered on our financial targets. We have a record win of new projects, not only new projects, also new innovation on IP side. So phenomenal year, number one. Number two, the transformation that we went through over the past four years, selling off the B2C business, selling diabetes care is done. This is now a pure play company, very focused, a company that we will all have a lot of fun with. And number three, this is also a very disciplined organization. And I look into Ypsomed, how...